Planet Labs PBC (PL) stock
PLNYSERadio & Tv Broadcasting & Communications EquipmentFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 4/30270% above fair value
$13.90−0.44 (-3.07%)
Close on Nov 12, 2026Market cap $5.06BP/E –Yield –
Earnings
Planet Labs PBC's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Next report
Dec 9, 2026
Q3 FY2027 · estimated, after the close
Revenue, Q2 FY2027
$116.10M
+58.2% on a year earlier
non-GAAP net income per share, Q2 FY2027
$0.02
-$0.03 a year earlier
Latest guidance
Raised
Sep 3, 2026 · 8 items
Quarterly results
Revenue and earnings per share from each of Planet Labs PBC's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2027ended Oct 31, 2026 | Dec 9, 2026Expected | – | – | – | – | – |
| Q2 FY2027ended Jul 31, 2026 | Sep 3, 2026after the close | $116.10M | +58.2% | -$0.03 | $0.02 | Release |
| Q1 FY2027ended Apr 30, 2026 | Jun 4, 2026after the close | $94.20M | +42.1% | -$0.40 | -$0.03 | Release |
| Q4 FY2026ended Jan 31, 2026 | Mar 19, 2026after the close | $86.80M | +40.9% | -$0.48 | $0.00 | Release |
| Q3 FY2026ended Oct 31, 2025 | Dec 10, 2025after the close | $81.30M | +32.6% | -$0.19 | $0.00 | Release |
| Q2 FY2026ended Jul 31, 2025 | Sep 8, 2025before the open | $73.40M | +20.1% | -$0.07 | -$0.03 | Release |
| Q1 FY2026ended Apr 30, 2025 | Jun 4, 2025after the close | $66.30M | +9.8% | -$0.04 | $0.00 | Release |
| Q4 FY2025ended Jan 31, 2025 | Mar 20, 2025after the close | $61.60M | +4.6% | -$0.12 | -$0.08 | Release |
| Q3 FY2025ended Oct 31, 2024 | Dec 9, 2024after the close | $61.30M | +10.6% | -$0.07 | -$0.02 | Release |
| Q2 FY2025ended Jul 31, 2024 | Sep 5, 2024after the close | $61.10M | +13.6% | -$0.13 | -$0.06 | Release |
| Q1 FY2025ended Apr 30, 2024 | Jun 6, 2024after the close | $60.40M | +14.6% | -$0.10 | -$0.05 | Release |
| Q4 FY2024ended Jan 31, 2024 | Mar 28, 2024after the close | $58.90M | +11.1% | -$0.11 | -$0.06 | Release |
| Q3 FY2024ended Oct 31, 2023 | Dec 7, 2023after the close | $55.40M | +11.5% | -$0.13 | -$0.05 | Release |
| Q2 FY2024ended Jul 31, 2023 | Sep 7, 2023after the close | $53.80M | +10.9% | -$0.14 | -$0.07 | Release |
| Q1 FY2024ended Apr 30, 2023 | Jun 8, 2023after the close | $52.70M | +31.4% | -$0.13 | -$0.07 | Release |
| Q4 FY2023ended Jan 31, 2023 | Mar 29, 2023after the close | $53.00M | +42.9% | -$0.14 | -$0.08 | Release |
| Q3 FY2023ended Oct 31, 2022 | Dec 14, 2022after the close | $49.70M | +56.8% | -$0.15 | -$0.08 | Release |
| Q2 FY2023ended Jul 31, 2022 | Sep 12, 2022after the close | $48.50M | – | -$0.15 | -$0.07 | Release |
| Q1 FY2023ended Apr 30, 2022 | Jun 14, 2022after the close | $40.10M | – | -$0.17 | – | Release |
| Q4 FY2022ended Jan 31, 2022 | Mar 31, 2022after the close | $37.10M | – | -$0.26 | – | Release |
| Q3 FY2022ended Sep 30, 2021 | Dec 13, 2021after the close | $31.70M | – | -$1.38 | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Planet Labs PBC's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| revenue | Q3 FY2027 | $101.00M – $105.00M | – | New | Sep 3, 2026 |
| Non-GAAP gross marginnon-GAAP | Q3 FY2027 | 56% – 58% | – | New | Sep 3, 2026 |
| Adjusted EBITDA lossnon-GAAP | Q3 FY2027 | -$6.00M – -$1.00M | – | New | Sep 3, 2026 |
| Capital expenditures | Q3 FY2027 | $30.00M – $37.00M | – | New | Sep 3, 2026 |
| revenue | FY2027 | $430.00M – $441.00M | $425.00M – $441.00M | Raised | Sep 3, 2026 |
| Non-GAAP gross marginnon-GAAP | FY2027 | 55% – 57% | 52% – 54% | Raised | Sep 3, 2026 |
| Adjusted EBITDA profitnon-GAAP | FY2027 | $3.00M – $10.00M | $0 – $10.00M | Raised | Sep 3, 2026 |
| Adjusted EBITDA profit | FY2027 | $0 – $10.00M | – | New | Jun 4, 2026 |
| Capital expenditures | FY2027 | $100.00M – $115.00M | $80.00M – $95.00M | Raised | Sep 3, 2026 |
Guidance vs results
The last range Planet Labs PBC gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2027 | Revenue | $102.00M – $107.00M | $116.10M | Above range |
| Q1 FY2027 | Revenue | $87.00M – $91.00M | $94.20M | Above range |
| FY2026 | Revenue | $297.00M – $301.00M | $307.80MΣ4Q | Above range |
| Q4 FY2026 | Revenue | $76.00M – $80.00M | $86.80M | Above range |
| Q3 FY2026 | Revenue | $71.00M – $74.00M | $81.30M | Above range |
| Q2 FY2026 | Revenue | $65.00M – $67.00M | $73.40M | Above range |
| Q1 FY2026 | Revenue | $61.00M – $63.00M | $66.30M | Above range |
| Q4 FY2025 | Revenue | $61.00M – $63.00M | $61.60M | Within range |
| Q3 FY2025 | Revenue | $61.00M – $64.00M | $61.30M | Within range |
| Q2 FY2025 | Revenue | $59.00M – $63.00M | $61.10M | Within range |
| Q1 FY2025 | Revenue | $58.00M – $61.00M | $60.40M | Within range |
| Q4 FY2024 | Revenue | $56.00M – $59.00M | $58.90M | Within range |
| Q3 FY2024 | Revenue | $54.00M – $56.00M | $55.40M | Within range |
| Q2 FY2024 | Revenue | $53.00M – $55.00M | $53.80M | Within range |
| Q1 FY2024 | Revenue | $51.00M – $54.00M | $52.70M | Within range |
| Q4 FY2023 | Revenue | $50.00M – $54.00M | $53.00M | Within range |
| Q3 FY2023 | Revenue | $45.00M – $48.00M | $49.70M | Above range |
| Q2 FY2023 | Revenue | $41.00M – $43.00M | $48.50M | Above range |
| Q1 FY2023 | Revenue | $38.00M – $41.00M | $40.10M | Within range |
| Q4 FY2022 | Revenue | $35.00M – $37.00M | $37.10M | Above range |
Guidance history
Every forecast Planet Labs PBC put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Sep 3, 2026 | Capital expenditures | FY2027 | $100.00M – $115.00M | Raised |
| Sep 3, 2026 | Capital expenditures | Q3 FY2027 | $30.00M – $37.00M | New |
| Sep 3, 2026 | Adjusted EBITDA profit | FY2027 | $3.00M – $10.00M | Raised |
| Sep 3, 2026 | Adjusted EBITDA loss | Q3 FY2027 | -$6.00M – -$1.00M | New |
| Sep 3, 2026 | Non-GAAP gross margin | FY2027 | 55% – 57% | Raised |
| Sep 3, 2026 | Non-GAAP gross margin | Q3 FY2027 | 56% – 58% | New |
| Sep 3, 2026 | revenue | FY2027 | $430.00M – $441.00M | Raised |
| Sep 3, 2026 | revenue | Q3 FY2027 | $101.00M – $105.00M | New |
| Jun 4, 2026 | Capital expenditures | FY2027 | $80.00M – $95.00M | Reaffirmed |
| Jun 4, 2026 | Capital expenditures | Q2 FY2027 | $21.00M – $27.00M | New |
| Jun 4, 2026 | Adjusted EBITDA profit | FY2027 | $0 – $10.00M | New |
| Jun 4, 2026 | Adjusted EBITDA profit | Q2 FY2027 | $0 – $5.00M | New |
| Jun 4, 2026 | Non-GAAP gross margin | FY2027 | 52% – 54% | Raised |
| Jun 4, 2026 | Non-GAAP gross margin | Q2 FY2027 | 52% – 55% | New |
| Jun 4, 2026 | revenue | FY2027 | $425.00M – $441.00M | Raised |
| Jun 4, 2026 | revenue | Q2 FY2027 | $102.00M – $107.00M | New |
| Mar 19, 2026 | Capital expenditures | FY2027 | $80.00M – $95.00M | New |
| Mar 19, 2026 | Capital expenditures | Q1 FY2027 | $17.00M – $23.00M | New |
| Mar 19, 2026 | Adjusted EBITDA profit | FY2027 | $0 – $10.00M | New |
| Mar 19, 2026 | Adjusted EBITDA loss | Q1 FY2027 | -$6.00M – -$3.00M | New |
| Mar 19, 2026 | Non-GAAP gross margin | FY2027 | 50% – 52% | New |
| Mar 19, 2026 | Non-GAAP gross margin | Q1 FY2027 | 49% – 51% | New |
| Mar 19, 2026 | revenue | FY2027 | $415.00M – $440.00M | New |
| Mar 19, 2026 | revenue | Q1 FY2027 | $87.00M – $91.00M | New |
| Dec 10, 2025 | Capital expenditures | FY2026 | $81.00M – $85.00M | Raised |
| Dec 10, 2025 | Capital expenditures | Q4 FY2026 | $22.00M – $26.00M | New |
| Dec 10, 2025 | Adjusted EBITDA profit | FY2026 | $6.00M – $8.00M | Raised |
| Dec 10, 2025 | Adjusted EBITDA loss | Q4 FY2026 | -$7.00M – -$5.00M | New |
| Dec 10, 2025 | Non-GAAP gross margin | FY2026 | 57% – 58% | Raised |
| Dec 10, 2025 | Non-GAAP gross margin | Q4 FY2026 | 50% – 52% | New |
| Dec 10, 2025 | revenue | FY2026 | $297.00M – $301.00M | Raised |
| Dec 10, 2025 | revenue | Q4 FY2026 | $76.00M – $80.00M | New |
| Sep 8, 2025 | Capital expenditures | FY2026 | $65.00M – $75.00M | Raised |
| Sep 8, 2025 | Capital expenditures | Q3 FY2026 | $18.00M – $24.00M | New |
| Sep 8, 2025 | Adjusted EBITDA loss | FY2026 | -$7.00M – $0 | Raised |
| Sep 8, 2025 | Adjusted EBITDA loss | Q3 FY2026 | -$4.00M – $0 | New |
| Sep 8, 2025 | Non-GAAP gross margin | FY2026 | 55% – 57% | Reaffirmed |
| Sep 8, 2025 | Non-GAAP gross margin | Q3 FY2026 | 55% – 56% | New |
| Sep 8, 2025 | revenue | FY2026 | $281.00M – $289.00M | Raised |
| Sep 8, 2025 | revenue | Q3 FY2026 | $71.00M – $74.00M | New |
| Jun 4, 2025 | Capital expenditures | FY2026 | $50.00M – $65.00M | Reaffirmed |
| Jun 4, 2025 | Capital expenditures | Q2 FY2026 | $17.00M – $22.00M | New |
| Jun 4, 2025 | Adjusted EBITDA loss | FY2026 | -$12.00M – -$7.00M | Raised |
| Jun 4, 2025 | Adjusted EBITDA loss | Q2 FY2026 | -$4.00M – -$2.00M | New |
| Jun 4, 2025 | Non-GAAP gross margin | FY2026 | 55% – 57% | Reaffirmed |
| Jun 4, 2025 | Non-GAAP gross margin | Q2 FY2026 | 56% – 57% | New |
| Jun 4, 2025 | revenue | FY2026 | $265.00M – $280.00M | Raised |
| Jun 4, 2025 | revenue | Q2 FY2026 | $65.00M – $67.00M | New |
| Mar 20, 2025 | Capital Expenditures | FY2026 | $50.00M – $65.00M | New |
| Mar 20, 2025 | Capital Expenditures | Q1 FY2026 | $11.00M – $16.00M | New |
| Mar 20, 2025 | Adjusted EBITDA loss | FY2026 | -$13.00M – -$7.00M | New |
| Mar 20, 2025 | Adjusted EBITDA loss | Q1 FY2026 | -$3.00M – -$2.00M | New |
| Mar 20, 2025 | Non-GAAP Gross Margin | FY2026 | 55% – 57% | New |
| Mar 20, 2025 | Non-GAAP Gross Margin | Q1 FY2026 | 58% – 60% | New |
| Mar 20, 2025 | revenue | FY2026 | $260.00M – $280.00M | New |
| Mar 20, 2025 | revenue | Q1 FY2026 | $61.00M – $63.00M | New |
| Dec 9, 2024 | Capital Expenditures | Q4 FY2025 | $8.00M – $11.00M | New |
| Dec 9, 2024 | Adjusted EBITDA | Q4 FY2025 | $0 – $2.00M | New |
| Dec 9, 2024 | Non-GAAP Gross Margin | Q4 FY2025 | 63% – 65% | New |
| Dec 9, 2024 | revenue | Q4 FY2025 | $61.00M – $63.00M | New |
| Sep 5, 2024 | Capital Expenditures | Q3 FY2025 | $13.00M – $16.00M | New |
| Sep 5, 2024 | Adjusted EBITDA loss | Q3 FY2025 | -$5.00M – -$2.00M | New |
| Sep 5, 2024 | Non-GAAP Gross Margin | Q3 FY2025 | 59% – 61% | New |
| Sep 5, 2024 | revenue | Q3 FY2025 | $61.00M – $64.00M | New |
| Jun 6, 2024 | Capital Expenditures | Q2 FY2025 | $14.00M – $17.00M | New |
| Jun 6, 2024 | Adjusted EBITDA loss | Q2 FY2025 | -$10.00M – -$7.00M | New |
| Jun 6, 2024 | Non-GAAP Gross Margin | Q2 FY2025 | 51% – 53% | New |
| Jun 6, 2024 | revenue | Q2 FY2025 | $59.00M – $63.00M | New |
| Mar 28, 2024 | Capital Expenditures | Q1 FY2025 | $14.00M – $17.00M | New |
| Mar 28, 2024 | Adjusted EBITDA loss | Q1 FY2025 | -$11.00M – -$9.00M | New |
| Mar 28, 2024 | Non-GAAP Gross Margin | Q1 FY2025 | 50% – 52% | New |
| Mar 28, 2024 | revenue | Q1 FY2025 | $58.00M – $61.00M | New |
| Dec 7, 2023 | Capital Expenditures as a Percentage of Revenue | Q4 FY2024 | 25% – 27% | New |
| Dec 7, 2023 | Capital Expenditures as a Percentage of Revenue | FY2024 | 21% – 22% | Lowered |
| Dec 7, 2023 | Adjusted EBITDA loss | Q4 FY2024 | -$12.00M – -$9.00M | New |
| Dec 7, 2023 | Adjusted EBITDA loss | FY2024 | -$58.00M – -$55.00M | Raised |
| Dec 7, 2023 | Non-GAAP Gross Margin | Q4 FY2024 | 52% – 56% | New |
| Dec 7, 2023 | Non-GAAP Gross Margin | FY2024 | 53% – 54% | Raised |
| Dec 7, 2023 | revenue | Q4 FY2024 | $56.00M – $59.00M | New |
| Dec 7, 2023 | revenue | FY2024 | $218.00M – $221.00M | Lowered |
| Sep 7, 2023 | Capital Expenditures as a Percentage of Revenue | Q3 FY2024 | 22% – 25% | New |
| Sep 7, 2023 | Capital Expenditures as a Percentage of Revenue | FY2024 | 22% – 23% | Raised |
| Sep 7, 2023 | Adjusted EBITDA loss | Q3 FY2024 | -$15.00M – -$13.00M | New |
| Sep 7, 2023 | Adjusted EBITDA loss | FY2024 | -$63.00M – -$55.00M | Raised |
| Sep 7, 2023 | Non-GAAP Gross Margin | Q3 FY2024 | 50% – 52% | New |
| Sep 7, 2023 | Non-GAAP Gross Margin | FY2024 | 52% – 54% | Reaffirmed |
| Sep 7, 2023 | revenue | Q3 FY2024 | $54.00M – $56.00M | New |
| Sep 7, 2023 | revenue | FY2024 | $216.00M – $223.00M | Lowered |
| Jun 8, 2023 | Capital Expenditure as a Percentage of Revenue | Q2 FY2024 | 19% – 25% | New |
| Jun 8, 2023 | Capital Expenditure as a Percentage of Revenue | FY2024 | 20% – 23% | Raised |
| Jun 8, 2023 | Adjusted EBITDA loss | Q2 FY2024 | -$20.00M – -$17.00M | New |
| Jun 8, 2023 | Adjusted EBITDA loss | FY2024 | -$67.00M – -$58.00M | Lowered |
| Jun 8, 2023 | Non-GAAP Gross Margin | Q2 FY2024 | 48% – 49% | New |
| Jun 8, 2023 | Non-GAAP Gross Margin | FY2024 | 52% – 54% | Lowered |
| Jun 8, 2023 | revenue | Q2 FY2024 | $53.00M – $55.00M | New |
| Jun 8, 2023 | revenue | FY2024 | $225.00M – $235.00M | New |
| Mar 29, 2023 | Capital Expenditure as a Percentage of Revenue | Q1 FY2024 | 20% – 24% | New |
| Mar 29, 2023 | Capital Expenditure as a Percentage of Revenue | FY2024 | 18% – 21% | New |
| Mar 29, 2023 | Adjusted EBITDA loss | Q1 FY2024 | -$21.00M – -$18.00M | New |
| Mar 29, 2023 | Adjusted EBITDA loss | FY2024 | -$47.00M – -$37.00M | New |
| Mar 29, 2023 | Non-GAAP Gross Margin | Q1 FY2024 | 53% – 55% | New |
| Mar 29, 2023 | Non-GAAP Gross Margin | FY2024 | 57% – 61% | New |
| Mar 29, 2023 | revenue | Q1 FY2024 | $51.00M – $54.00M | New |
| Mar 29, 2023 | revenue | FY2024 | $248.00M – $268.00M | New |
| Dec 14, 2022 | Capital Expenditure as a Percentage of Revenue | Q4 FY2023 | 8% – 11% | New |
| Dec 14, 2022 | Capital Expenditure as a Percentage of Revenue | FY2023 | 8% – 9% | Lowered |
| Dec 14, 2022 | Adjusted EBITDA | Q4 FY2023 | -$21.00M – -$16.00M | New |
| Dec 14, 2022 | Adjusted EBITDA | FY2023 | -$60.00M – -$56.00M | Raised |
| Dec 14, 2022 | Non-GAAP Gross Margin | FY2023 | 52% – 53% | Raised |
| Dec 14, 2022 | Non-GAAP Gross Margin | Q4 FY2023 | 56% – 59% | New |
| Dec 14, 2022 | revenue | Q4 FY2023 | $50.00M – $54.00M | New |
| Dec 14, 2022 | revenue | FY2023 | $188.00M – $192.00M | Raised |
| Sep 12, 2022 | Capital Expenditure as a Percentage of Revenue | Q3 FY2023 | 16% – 19% | New |
| Sep 12, 2022 | Capital Expenditure as a Percentage of Revenue | FY2023 | 13% – 15% | Raised |
| Sep 12, 2022 | Adjusted EBITDA | Q3 FY2023 | -$22.00M – -$20.00M | New |
| Sep 12, 2022 | Adjusted EBITDA | FY2023 | -$68.00M – -$60.00M | Raised |
| Sep 12, 2022 | Non-GAAP Gross Margin | Q3 FY2023 | 47% – 49% | New |
| Sep 12, 2022 | Non-GAAP Gross Margin | FY2023 | 49% – 51% | Raised |
| Sep 12, 2022 | revenue | Q3 FY2023 | $45.00M – $48.00M | New |
| Sep 12, 2022 | revenue | FY2023 | $182.00M – $190.00M | Raised |
| Jun 14, 2022 | Capital Expenditure as a Percentage of Revenue | Q2 FY2023 | 12% – 14% | New |
| Jun 14, 2022 | Capital Expenditure as a Percentage of Revenue | FY2023 | 11% – 13% | Lowered |
| Jun 14, 2022 | Adjusted EBITDA | Q2 FY2023 | -$18.00M – -$16.00M | New |
| Jun 14, 2022 | Adjusted EBITDA | FY2023 | -$70.00M – -$60.00M | Narrowed |
| Jun 14, 2022 | Non-GAAP Gross Margin | Q2 FY2023 | 44% – 46% | New |
| Jun 14, 2022 | Non-GAAP Gross Margin | FY2023 | 47% – 49% | Narrowed |
| Jun 14, 2022 | revenue | Q2 FY2023 | $41.00M – $43.00M | New |
| Jun 14, 2022 | revenue | FY2023 | $177.00M – $187.00M | New |
| Mar 31, 2022 | Capital Expenditure as a Percentage of Revenue | Q1 FY2023 | 8% – 9% | New |
| Mar 31, 2022 | Capital Expenditure as a Percentage of Revenue | FY2023 | 12% – 13% | New |
| Mar 31, 2022 | Adjusted EBITDA | Q1 FY2023 | -$17.00M – -$14.00M | New |
| Mar 31, 2022 | Adjusted EBITDA | FY2023 | -$75.00M – -$50.00M | New |
| Mar 31, 2022 | Non-GAAP Gross Margin | Q1 FY2023 | 38% – 45% | New |
| Mar 31, 2022 | Non-GAAP Gross Margin | FY2023 | 43% – 50% | New |
| Mar 31, 2022 | revenue | Q1 FY2023 | $38.00M – $41.00M | New |
| Mar 31, 2022 | revenue | FY2023 | $170.00M – $190.00M | New |
| Dec 13, 2021 | capex spend | Q4 FY2022 | $5.00M – $7.00M | New |
| Dec 13, 2021 | Adjusted EBITDA loss | Q4 FY2022 | -$17.00M – -$15.00M | New |
| Dec 13, 2021 | Non-GAAP Gross Margin percentage | Q4 FY2022 | 37% – 39% | New |
| Dec 13, 2021 | revenue | Q4 FY2022 | $35.00M – $37.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Planet Labs PBC filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- News
- News
- Results
- Update
- Results
- Planet Labs Announces Proposed Private Offering of $300,000,000 of Convertible Senior Notes Due 2030News
- News
- Update
- Results
- Update
- Results
- Results
See a number that looks wrong?